Scheurer Stephan, Sonnewald Sophia
Paul-Ehrlich-Institut, Division Allergology, Paul-Ehrlich-Str. 51-59, Langen, Germany.
Front Biosci (Landmark Ed). 2009 Jan 1;14(1):59-71. doi: 10.2741/3231.
Food allergies are a major health concern in industrialized countries. Since a specific immunotherapy for food allergies is not available in clinical routine praxis till now, reduction of allergens in foods, either by food processing or genetic engineering are strategies to minimize the risk of adverse reactions for food allergic patients. This review summarizes biotechnological approaches, especially the RNA interference (RNAi) technology, for the reduction of selected allergens in plant foods. So far, only a limited number of reports showing proof-of-concept of this methodology are available. Using RNAi an impressive reduction of allergen accumulation was obtained which was stable in the next generations of plants. Since threshold doses for most food allergens are not known, the beneficial effect has to be evaluated by oral challenge tests in the future. The article critically addresses the potential and limitations of genetic engineering, as well as of alternative strategies to generate "low allergic" foods.
食物过敏是工业化国家主要的健康问题。由于目前临床常规实践中尚无针对食物过敏的特异性免疫疗法,通过食品加工或基因工程减少食物中的过敏原是降低食物过敏患者不良反应风险的策略。这篇综述总结了用于减少植物性食物中特定过敏原的生物技术方法,尤其是RNA干扰(RNAi)技术。到目前为止,仅有数量有限的报告证明了该方法的概念验证。使用RNAi可显著减少过敏原积累,且在植物的下一代中保持稳定。由于大多数食物过敏原的阈值剂量尚不清楚,未来必须通过口服激发试验来评估其有益效果。本文批判性地探讨了基因工程以及生产“低过敏”食物的替代策略的潜力和局限性。